These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 2074261
1. Recent observations on the pathophysiology of thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Moake JL. Hematol Pathol; 1990; 4(4):197-201. PubMed ID: 2074261 [No Abstract] [Full Text] [Related]
2. The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS). Moake JL. Prog Clin Biol Res; 1990; 337():135-40. PubMed ID: 2191307 [No Abstract] [Full Text] [Related]
3. von Willebrand factor in thrombotic thrombocytopenic purpura. Furlan M, Lämmle B. Thromb Haemost; 1999 Aug; 82(2):592-600. PubMed ID: 10605756 [No Abstract] [Full Text] [Related]
4. [Treatment of the hemolytic-uremic syndrome and thrombotic thrombopenic purpura]. Villegas A, Alvarez-Sala JL, Espinós D. Sangre (Barc); 1983 Aug; 28(5):635-41. PubMed ID: 6364423 [No Abstract] [Full Text] [Related]
5. von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Moake JL, McPherson PD. Transfus Med Rev; 1990 Apr; 4(2):163-8. PubMed ID: 2134624 [No Abstract] [Full Text] [Related]
6. Apoptosis of microvascular endothelial cells in the pathophysiology of thrombotic thrombocytopenic purpura/sporadic hemolytic uremic syndrome. Laurence J, Mitra D. Semin Hematol; 1997 Apr; 34(2):98-105. PubMed ID: 9109211 [No Abstract] [Full Text] [Related]
14. [Significance of the determination of prostacyclin metabolism in the management of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura]. Túri S, Beattie JT. Orv Hetil; 1986 Jul 20; 127(29):1747-51. PubMed ID: 3526247 [No Abstract] [Full Text] [Related]
15. [Pathogenesis of hemolytic uremic syndrome and thrombotic thrombocytopenia purpura]. Gruenbaum G, Shoenfeld Y. Harefuah; 1997 May 01; 132(9):665-9. PubMed ID: 9225585 [No Abstract] [Full Text] [Related]
16. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review. Bosch T, Wendler T. Ther Apher; 2001 Jun 01; 5(3):182-5. PubMed ID: 11467754 [Abstract] [Full Text] [Related]
18. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM). Zeigler ZR, Rosenfeld CS, Andrews DF, Nemunaitis J, Raymond JM, Shadduck RK, Kramer RE, Gryn JF, Rintels PB, Besa EC, George JN. Am J Hematol; 1996 Dec 01; 53(4):213-20. PubMed ID: 8948657 [Abstract] [Full Text] [Related]
19. [Treatment of thrombocytopenic thrombotic purpura]. Corte Buelga JR, Rodríguez Vicente P, García Gala JM, Alonso García AM, Martínez Revuelta E. Sangre (Barc); 1997 Feb 01; 42(1):53-61. PubMed ID: 9229804 [No Abstract] [Full Text] [Related]
20. [Thrombotic thrombocytopenic purpura--new insights in the pathogenesis, diagnosis and modern therapy]. Misgav M, Berliner S, Eldor A. Harefuah; 2001 Jul 01; 140(7):653-7. PubMed ID: 11481974 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]